All results

109 results

• 1305-0023 (FIBRONEERTM ILD)

  This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary…

  Ages

  18 Years - N/A

  Sexes

  All

• A Multi-Center, Open-Label, Phase 1/2 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity

  AB-101 is an off-the shelf, allogeneic cell product made of "natural killer" cells, also called NK cells. White blood cells are part of the immune system and…

  Ages

  18 Years - N/A

  Sexes

  All

• A Study of ASP1002 in Adults for Treatment of Solid Tumors

  ASP1002 is a potential new treatment for people with certain solid tumors. Before ASP1002 is available as a treatment, the researchers need to understand how…

  Ages

  18 Years - N/A

  Sexes

  All

• A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Pts w/ MIBC

  The purpose of this study is to evaluate the anti-tumor effects of TAR-200 in combination with intravenous (IV) cetrelimab and IV cetrelimab alone. Bladder…

  Ages

  18 Years - N/A

  Sexes

  All

• ABRuPT2

  This is a prospective randomized multi-center study which will compare acute fluid resuscitation using a colloid strategy (LR + 5% Albumin) to a crystalloid…

  Ages

  18 Years - N/A

  Sexes

  All

• ABX Nail Study

  This prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those…

  Ages

  18 Years - N/A

  Sexes

  All

• ACTIV-4d or Novel Experimental COVID Therapies Affecting Host Response (NECTAR)

  The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients…

  Ages

  18 Years - N/A

  Sexes

  All

• AD Sleep Disturbance

  The purpose of the study is to evaluate the effect of ruxolitinib cream on sleep disturbances with participants with Atopic Dermatitis. ### Inclusion…

  Ages

  18 Years - N/A

  Sexes

  All

• ALTA TIPS

  ALTA is a multicenter consortium focused on the management of portal hypertension. ALTA TIPS is a longitudinal observational study of patients who are…

  Ages

  18 Years - N/A

  Sexes

  All

• ANCHOR

  This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP. ### Inclusion criteria: * Participants with 18 years…

  Ages

  18 Years - N/A

  Sexes

  All